Training of a new generation of young researchers
 
ISPIC will recruit 19 ESRs (see table below). Our selection of those 20 unique ESRs on the ISPIC project reflects the recommendations of the Society for Immunotherapy of Cancer (SITC), where the area of cancer immunotherapy requires people of different skill sets, working within teams, which would come together to translate this research into the clinic. This means not every ESR should be trained and registered for a PhD and work for three years.



Early Stage Researcher (ESR)

Lead
Partner

PhD
enrolment

Start month - End month

Duration

ESR 1


Yes - UB

7 - 42

36

ESR 2


No

7 - 30

24

ESR 3


Yes - TUD

7 - 42

36

ESR 4


No

7 - 24

18

ESR 6


Yes - LUMC

7 - 42

36

ESR 7


Yes - UVA

7 - 42

36

ESR 8


Yes - LUMC

7 - 42

36

ESR 9


Yes - UB

7 - 42

36

ESR 10


No

7 - 18

12

ESR 11


Yes - EMC

7 - 42

36

ESR 12


Yes - UC

7 - 42

36

ESR 13


No

7 - 24

18

ESR 14


Yes - EPFL

7 - 42

36

ESR 15


Yes - US

7 - 42

36

ESR 16


No

7 -18

12

ESR 17


Yes - LUMC

7 - 42

36

ESR 18


No

7 -18

12

ESR 19


Yes - LUMC

7 - 42

36

ESR 20

EMC

No

7 -24

18

We have identified also a need for shorter term training of between 12 - 24 months that would be sufficient for some ESRs. For example, perhaps a young immunologist needs to understanding about PLGA chemistry but has no requirement to study academically for it but only needs it for a practical purpose to know how to encapsulate their immunoregulatory reagents. Our 20 ESRs have therefore been divided into 11 of those to be registered as PhDs on 36 month programs and the other 9 to be trained in specific complementary skills, such as an applied novel technology, e.g. PLGA, UCNPs, MSI or bioinformatics, over a shorter term. There will be three ESRs who are eligible and will register transnationally outside of their own country in order to sow the seeds for better integrative cross-border collaboration. This also assures the availability of a structured academic-industrial training program provided in conjunction with those PhD registrations. Therefore, ESR8 from MEDRES will register for a PhD with academic and secondment partner, LUMC, where there are MRI facilities and additional research links. ESR7 from JENA will register for a PhD with academic and secondment partner, MAAS, where there are ongoing collaborations between the two sites. ESR6 from TECO will register for a PhD with academic and secondment partner, UVA, to investigate tumour immunology and imaging more closely on the new UCPN platform. In addition ESR1 that will be supervised by HH but the PhD enrolment will be done through the structured 3-year PhD programmes from the Doctoral School in UB. All ESRs will participate the training programme, which will be overseen and evaluated by the Supervisory Board (SB) to further ensure an equal level of training, supervision and assessment throughout partner institutions, transparency, and internal dissemination of best practice.
To achieve consistency and quality, the training programme will be divided into the following 4 Training Packages (TPs):
            (TP1) Training-by Research,
            (TP2) Network-wide Events,
            (TP3) Transferable Skills and
            (TP4) Intersectoral Training.